期刊文献+

Gastrectomy impact on the gut microbiome in patients with gastric cancer:A comprehensive review

下载PDF
导出
摘要 Gastric cancer is one of the most common malignancies worldwide and gastrectomy remains the only potentially curative treatment option for this disease.However,the surgery leads to significant physiological and anatomical changes in the gastrointestinal(GI)tract including loss of the gastric barrier,an increase in oxygenation levels in the distal gut,and biliary diversion after gastrectomy.These changes in the GI tract influence the composition of the gut microbiome and thus,host health.Gastrectomy-induced dysbiosis is characterized by increased abundance of typical oral cavity bacteria,an increase in aero-tolerant bacteria(aerobes/facultative anaerobes),and increased abundance of bile acidtransforming bacteria.Furthermore,this dysbiosis is linked to intestinal inflammation,small intestinal bacterial overgrowth,various GI symptoms,and an increased risk of colorectal cancer.
出处 《World Journal of Gastrointestinal Surgery》 SCIE 2021年第7期678-688,共11页 世界胃肠外科杂志(英文版)(电子版)
  • 相关文献

参考文献1

二级参考文献10

  • 1Ilfet Songun,Hein Putter,Elma Meershoek-Klein Kranenbarg,Mitsuru Sasako,Cornelis JH van de Velde.Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial[J]. Lancet Oncology . 2010 (5)
  • 2Rebecca Siegel,Deepa Naishadham,Ahmedin Jemal.Cancer statistics, 2013[J]. CA: A Cancer Journal for Clinicians . 2013 (1)
  • 3Hyun-Dong Chae,In-Ho Kim,Geon Ho Lee,Im-Hee Shin,Hun-Suk Suh,Chang-Ho Jeon.Gastric Cancer Detection Using Gastric Juice Pepsinogen and Melanoma-Associated Gene RNA[J].American Journal of Clinical Pathology.2013(2)
  • 4Kelly Morris.Revising the Declaration of Helsinki[J].The Lancet.2013(9881)
  • 5C. Jonasson,B. Wernersson,D. A. L. Hoff,J. G. Hatlebakk.Validation of the GerdQ questionnaire for the diagnosis of gastro‐oesophageal reflux disease[J].Aliment Pharmacol Ther.2013(5)
  • 6Mitchell L Schubert.Gastric secretion[J].Current Opinion in Gastroenterology.2010(6)
  • 7Christina Reimer,Peter Bytzer.Discontinuation of long-term proton pump inhibitor therapy in primary care patients: a randomized placebo-controlled trial in patients with symptom relapse[J].European Journal of Gastroenterology & Hepatology.2010(10)
  • 8David A. Johnson,Philip O. Katz,Doug Levine,Kerstin R?hss,Magnus ?strand,Ola Junghard,Péter Nagy.Prevention of Relapse of Healed Reflux Esophagitis is Related to the Duration of Intragastric pH>4[J].Journal of Clinical Gastroenterology.2010(7)
  • 9K. Iijima,T. Koike,Y. Abe,H. Yamagishi,N. Ara,K. Asanuma,K. Uno,A. Imatani,N. Nakaya,S. Ohara,T. Shimosegawa.Gastric Hyposecretion in Esophageal Squamous-Cell Carcinomas[J].Digestive Diseases and Sciences.2010(5)
  • 10Philip O. Katz,Stacey Zavala.Proton Pump Inhibitors in the Management of GERD[J].Journal of Gastrointestinal Surgery.2010(1)

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部